NEW YORK (GenomeWeb News) – Genetic testing startup Recombine said yesterday that it has raised $3.3 million in a Series A financing.

New York venture capital firm FirstMark Capital led the round, and other participants included Vast Ventures, Vivek Garipalli, Alexander Saint-Amand, as well as Flatiron Health Co-founders Zach Weinberg and Nat Turner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.